Case fatality among infants with congenital malformations by lethality

Kirk A Bol1, Russel S Rickard, Russell S Kirby

  • 1Colorado Responds to Children With Special Needs, Colorado Department of Public Health and Environment Denver 80246, USA. kirk.bol@state.co.us

Insights

Black/non-Hispanic mothers experienced higher infant mortality risk with less severe birth defects. This highlights disparities in infant mortality linked to maternal race and birth defect severity, warranting targeted prevention.

Area of Science:

  • Public Health
  • Perinatal Epidemiology
  • Reproductive Health

Background:

  • Congenital anomalies are the leading cause of infant death in the U.S.
  • Limited research exists on factors influencing mortality across different congenital anomaly types.
  • Understanding disparities in infant mortality is crucial for targeted interventions.

Purpose of the Study:

  • To investigate if maternal race and ethnicity influence infant mortality risk.
  • To assess this risk in relation to the severity of congenital malformations.
  • To identify potential disparities in infant mortality outcomes.

Main Methods:

  • Retrospective cohort analysis using Colorado's birth defects surveillance data (1995-2000).
  • Inclusion of infants with major congenital malformations, stratified by lethality.
  • Logistic regression analysis considering maternal race/ethnicity, birth weight, gestational age, maternal education, maternal age, and infant sex.

Main Results:

  • For low/very low lethality congenital anomalies, Black/non-Hispanic maternal race/ethnicity was linked to increased infant mortality risk (OR 2.81).
  • Low and very low birth weight were also significant risk factors in the low lethality group.
  • Maternal race/ethnicity was not a significant factor in high/very high lethality groups; however, birth weight and gestational age interaction increased mortality risk.

Conclusions:

  • Statewide birth defects surveillance data revealed a significant infant mortality disparity.
  • This disparity was identified in a specific population subset, suggesting a need for further investigation.
  • Findings support targeted prevention activities to address identified health inequities.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...